These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Structural brain abnormalities in Cushing's syndrome. Bauduin SEEC; van der Wee NJA; van der Werff SJA Curr Opin Endocrinol Diabetes Obes; 2018 Aug; 25(4):285-289. PubMed ID: 29746308 [TBL] [Abstract][Full Text] [Related]
6. Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing's disease: a case-control study. Andela CD; van der Werff SJ; Pannekoek JN; van den Berg SM; Meijer OC; van Buchem MA; Rombouts SA; van der Mast RC; Romijn JA; Tiemensma J; Biermasz NR; van der Wee NJ; Pereira AM Eur J Endocrinol; 2013 Dec; 169(6):811-9. PubMed ID: 24031092 [TBL] [Abstract][Full Text] [Related]
7. [Effects of glucocorticoids administration on memory. Cognitive impairment in Cushing's disease]. Martin-Du Pan RC; Berney P Rev Med Suisse; 2012 Nov; 8(362):2165-6, 2168-9. PubMed ID: 23240317 [TBL] [Abstract][Full Text] [Related]
8. Volumetric MRI analysis of hippocampal subregions in Cushing's disease: a model for glucocorticoid neural modulation. Toffanin T; Nifosì F; Follador H; Passamani A; Zonta F; Ferri G; Scanarini M; Amistà P; Pigato G; Scaroni C; Mantero F; Carollo C; Perini GI Eur Psychiatry; 2011 Jan; 26(1):64-7. PubMed ID: 21067899 [TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid resistance and hypersensitivity. Malchoff CD; Malchoff DM Endocrinol Metab Clin North Am; 2005 Jun; 34(2):315-26, viii. PubMed ID: 15850844 [TBL] [Abstract][Full Text] [Related]
10. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease. Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046 [TBL] [Abstract][Full Text] [Related]
11. Cognitive function and cerebral assessment in patients who have Cushing's syndrome. Bourdeau I; Bard C; Forget H; Boulanger Y; Cohen H; Lacroix A Endocrinol Metab Clin North Am; 2005 Jun; 34(2):357-69, ix. PubMed ID: 15850847 [TBL] [Abstract][Full Text] [Related]
12. Dynamic functional connectivity changes associated with psychiatric traits and cognitive deficits in Cushing's disease. Feng Z; Zhang H; Zhou T; Yu X; Zhang Y; Yan X Transl Psychiatry; 2023 Oct; 13(1):308. PubMed ID: 37798280 [TBL] [Abstract][Full Text] [Related]
16. Assessment of brain and hippocampal volume in patients with Cushing's disease. Frankowska E; Kidziński R; Zieliński G Endokrynol Pol; 2022; 73(5):823-830. PubMed ID: 36094872 [TBL] [Abstract][Full Text] [Related]
17. Circadian blood pressure profile in patients with active Cushing's disease and after long-term cure. Pecori Giraldi F; Toja PM; De Martin M; Maronati A; Scacchi M; Omboni S; Cavagnini F; Parati G Horm Metab Res; 2007 Dec; 39(12):908-14. PubMed ID: 18046661 [TBL] [Abstract][Full Text] [Related]
18. Impact of glucocorticoids and chronic stress on progression of Parkinson's disease. Kibel A; Drenjancević-Perić I Med Hypotheses; 2008 Dec; 71(6):952-6. PubMed ID: 18718724 [TBL] [Abstract][Full Text] [Related]
19. Aspects of human disease. 36. Cushing's disease. Scully C Dent Update; 2009; 36(6):381. PubMed ID: 19847945 [No Abstract] [Full Text] [Related]
20. Structural and functional brain alterations in Cushing's disease: A narrative review. Liu YF; Pan L; Feng M Front Neuroendocrinol; 2022 Oct; 67():101033. PubMed ID: 36126747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]